# Perimenopausal Estrogen Replacement Therapy Study

> **NCT01308814** · PHASE2,PHASE3 · COMPLETED · sponsor: **University of North Carolina, Chapel Hill** · enrollment: 172 (actual)

## Conditions studied

- Perimenopause
- Menopause
- Depression

## Interventions

- **DRUG:** Estradiol
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01308814
- **Lead sponsor:** University of North Carolina, Chapel Hill
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-10
- **Primary completion:** 2016-03
- **Final completion:** 2016-03
- **Target enrollment:** 172 (ACTUAL)
- **Last updated:** 2017-08-22

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01308814

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01308814, "Perimenopausal Estrogen Replacement Therapy Study". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01308814. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*